GlaxoSmithKline and the Oswald Cruz Foundation (Fiocruz) announced today a unique collaboration to research and develop new and innovative medicines to treat neglected diseases such as: malaria, tuberculosis, chagas, and leishmaniasis; the focus will be on chagas and leishmaniasis. This new collaboration will have a great impact on neglected diseases, there will now be a sharing of ideas, research, and resources all aiming toward an important and needy cause.
To read more about the announcement, click here!







